谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

EP05.02-002 Who Benefits More of Durvalumab after Chemoradiotherapy (CRT) in Real-World Patients with Locally Advanced Non-Small-Cell Lung Cancer (NSCLC)?

B. Tavara,M. L. Garrido,Z. Rodriguez,M. Rojas,L. Lopez,S. Medina, C. Ponte,A. Lopez,E. Sanchez,M. Pedraza, P. Vinals,M. Lopez,D. Alonso, A. Rodriguez,E. Davila,C. Castanon,L. M. De Sande,B. Nieto,M. E. Vallejo Pascual, J. D. L. R. Rodriguez,A. Garcia Palomo,P. Diz Tain

Journal of thoracic oncology（2022）

引用 0|浏览18
暂无评分
关键词
DURVALUMAB,PACIFIC,REAL WORLD DATA
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要